Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Submicroscopic deletions in 5q- associated malignancies.

Barbara Crescenzi1, Roberta La Starza, Silvia Romoli

  • 1Hematology and Bone Marrow Trasplantation Unit, University of Perugia, Italy.

Haematologica
|March 17, 2004
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early software-assisted response predicts survival in a prospective cohort of 258 newly diagnosed cGvHD patients.

Bone marrow transplantation·2026
Same author

Cardiovascular Complications and Subclinical Myocardial Dysfunction in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Cancers·2026
Same author

A phase II multicenter prospective study to evaluate the safety and efficacy of myeloablative-dose treosulfan plus fludarabine (FT14) conditioning regimen in allogeneic hematopoietic stem cell transplantation for AML patients aged 40-65 in first complete remission.

Bone marrow transplantation·2026
Same author

Durable remission despite transplantation with active disease in therapy-related NUP98::TOP1-rearranged acute myeloid leukemia.

Annals of hematology·2026
Same author

Inhibition of the Atypical Kinase WNK1 as a Therapeutic Strategy in TAL-related T-cell Acute Lymphoblastic Leukemia.

Blood·2026
Same author

A specific stem cell program and CD112 immunological axis dysfunctions underpinning monosomy 7-associated myeloid neoplasms.

Signal transduction and targeted therapy·2026

Isolated 5q deletion in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) indicates a stable clone. Complex karyotypes with 5q deletion suggest a mutator phenotype, distinguishing them from 5q- syndrome.

Area of Science:

  • Hematology
  • Cancer Genetics
  • Cytogenetics

Background:

  • The 5q deletion is a common aberration in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
  • This study investigated the presence of deletions in known suppressor gene sequences within myeloid malignancies exhibiting a 5q deletion.
  • The research aimed to differentiate molecular characteristics between isolated 5q deletions and those with additional chromosomal abnormalities.

Discussion:

  • Isolated 5q deletions in MDS and AML represent a stable clonal population.
  • Acute myeloid leukemia with isolated 5q deletion shares molecular similarities with 5q- syndrome.
  • The presence of additional karyotypic changes alongside a 5q deletion points towards a mutator phenotype.

Key Insights:

  • No additional suppressor gene deletions were detected in cases with isolated 5q deletions.

Related Experiment Videos

  • Mono-allelic deletions of suppressor genes (p53, AML1, D13S25, NF1, Ikaros) were identified in 66% of patients with 5q deletion and additional karyotypic changes.
  • Metaphase FISH analysis aided in localizing cryptic deletions to non-proliferating cells.

    • Outlook:

    • Further research into the mutator phenotype associated with complex karyotypes in myeloid malignancies is warranted.
    • Understanding the molecular basis of 5q deletions can refine diagnostic and prognostic strategies for MDS and AML.
    • Comparative genomic hybridization and whole-exome sequencing could provide deeper insights into the genetic landscape of 5q- associated myeloid cancers.